APA (7th ed.) Citation

Persha, H. E., Kato, S., De, P., Adashek, J. J., Sicklick, J. K., Subbiah, V., & Kurzrock, R. (2022). Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: Case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response. Journal of Hematology & Oncology, 15(1), 1. https://doi.org/10.1186/s13045-022-01344-x

Chicago Style (17th ed.) Citation

Persha, Hanna E., Shumei Kato, Pradip De, Jacob J. Adashek, Jason K. Sicklick, Vivek Subbiah, and Razelle Kurzrock. "Osteosarcoma with Cell-cycle and Fibroblast Growth Factor Genomic Alterations: Case Report of Molecular Tumor Board Combination Strategy Resulting in Long-term Exceptional Response." Journal of Hematology & Oncology 15, no. 1 (2022): 1. https://doi.org/10.1186/s13045-022-01344-x.

MLA (9th ed.) Citation

Persha, Hanna E., et al. "Osteosarcoma with Cell-cycle and Fibroblast Growth Factor Genomic Alterations: Case Report of Molecular Tumor Board Combination Strategy Resulting in Long-term Exceptional Response." Journal of Hematology & Oncology, vol. 15, no. 1, 2022, p. 1, https://doi.org/10.1186/s13045-022-01344-x.